DE69424974T2 - Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut - Google Patents

Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut

Info

Publication number
DE69424974T2
DE69424974T2 DE69424974T DE69424974T DE69424974T2 DE 69424974 T2 DE69424974 T2 DE 69424974T2 DE 69424974 T DE69424974 T DE 69424974T DE 69424974 T DE69424974 T DE 69424974T DE 69424974 T2 DE69424974 T2 DE 69424974T2
Authority
DE
Germany
Prior art keywords
nca
blood
colon cancer
monitoring
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69424974T
Other languages
English (en)
Other versions
DE69424974D1 (de
Inventor
William Jeffrey Allard
Kwok K Yeung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of DE69424974D1 publication Critical patent/DE69424974D1/de
Publication of DE69424974T2 publication Critical patent/DE69424974T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69424974T 1993-04-21 1994-04-21 Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut Expired - Fee Related DE69424974T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5093593A 1993-04-21 1993-04-21
US19397594A 1994-02-08 1994-02-08

Publications (2)

Publication Number Publication Date
DE69424974D1 DE69424974D1 (de) 2000-07-27
DE69424974T2 true DE69424974T2 (de) 2000-10-19

Family

ID=26728869

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424974T Expired - Fee Related DE69424974T2 (de) 1993-04-21 1994-04-21 Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut

Country Status (7)

Country Link
US (1) US6309846B1 (de)
EP (1) EP0628820B1 (de)
JP (1) JP3345696B2 (de)
AT (1) ATE194035T1 (de)
AU (1) AU681624B2 (de)
CA (1) CA2118760C (de)
DE (1) DE69424974T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118759C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood
EP0727664A3 (de) * 1995-02-15 1996-11-20 Bayer Ag Tumormarker für Nachweis des Wiederauftretens eines Brustkrebs
EP0747705A1 (de) * 1995-06-09 1996-12-11 Bayer Corporation Spezifische Bestimmung von NCA 90 Glykoprotein im Blut eines Krebspatienten
JP2004512023A (ja) * 2000-06-09 2004-04-22 コリクサ　コーポレイション 結腸癌の治療および診断のための組成物および方法
EP2784511A1 (de) * 2013-03-27 2014-10-01 Universität Zürich Integrin-alpha-v-beta 6 zur Diagnose/Prognose von Kolorektalkarzinomen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
CA2082605C (en) * 1991-12-30 2005-02-01 James J. Elting Monitoring of nca-bt in blood samples of breast cancer patients
CA2118759C (en) * 1993-04-21 2004-06-22 William Jeffrey Allard Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood

Also Published As

Publication number Publication date
ATE194035T1 (de) 2000-07-15
JPH06324044A (ja) 1994-11-25
EP0628820A2 (de) 1994-12-14
EP0628820A3 (de) 1995-09-06
CA2118760A1 (en) 1994-10-22
CA2118760C (en) 2004-06-22
AU681624B2 (en) 1997-09-04
US6309846B1 (en) 2001-10-30
AU5942094A (en) 1994-10-27
EP0628820B1 (de) 2000-06-21
JP3345696B2 (ja) 2002-11-18
DE69424974D1 (de) 2000-07-27

Similar Documents

Publication Publication Date Title
NO954897L (no) Fremgangsmåte for å bestemme et individs inflammasjonsindeks fra hele blodfibrinogen og hematokrit eller hemoglobinmålinger
CA2087720A1 (en) Method for analytically utilizing microfabricated sensors during wet-up
US5197017A (en) Potentiophotometric fibrinogen determination
FI941522A (fi) Menetelmä hemoglobiiniadditiotuotteiden määrittämiseksi
WO1995009559A3 (en) Detection of an acute myocardial infarction in a patient
Tola The effect of blood lead concentration, age, sex and time of exposure upon erythrocyte δ-aminolevulinic acid dehydratase activity
DE69424974D1 (de) Überwachung von Patienten mit Dickdarmkrebs durch Messung von NCA 50/90 im Blut
ATE195182T1 (de) Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut
SU1013853A1 (ru) Способ определени воспалительного процесса в организме
KR950703736A (ko) 치주염 발생의 사전 진단 방법 및 키트(methods and kits for evaluating risk of developing periodontitis)
Cheah et al. A rapid and simple blood sugar determination using the Ames reflectance meter and Dextrostix system: a preliminary report
EP0062616A1 (de) Verfahren zur Untersuchung der Blutgerinnung und der Thrombozyten-Verklumpung und Vorrichtung zur Ausführung dieses Verfahrens
Shimizu et al. A new automatic method for measuring cell electrophoretic mobility
ATE155891T1 (de) Immunoassay für nca-bt in blutproben von brustkrebspatientinnen
Gómez-Lechón et al. Measurement of fibronectin in human body fluids
EP0230343A3 (de) Verfahren zur Bestimmung von Glycerophosphaten in amniotischen Flüssigkeiten als diagnostischer Anzeiger
Adlercreutz et al. Determination of α-amylase in serum and urine of subjects with a low bicarbonate concentration in the duodenal aspirate after secretin stimulation
Knapp et al. Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls.
SU1666952A1 (ru) Способ контрол эффективности лечени юношеской артериальной гипертензии
SU1397836A1 (ru) Способ определени интоксикации организма тиомочевиной
Andreasen Predictive value of decreasing antithrombin III in deep-vein thrombosis
SU1122294A1 (ru) Способ определени нарушени кровообращени в исследуемой сосудистой зоне
Lizana et al. Electronic timing of a high-speed immunonephelometric continuous-flow system
SU1655468A1 (ru) Способ диагностики стадий печеночной недостаточности
DE3176408D1 (en) Method to check the validity of a breath sample for determining the blood-alcohol concentration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee